Influenza: FDA reporting patterns
110,351 FDA FAERS reports mention Influenza. 65,890 reports have a serious outcome flag.
Medicines named as suspect
- Adalimumab: 7,548 reports
- Etanercept: 7,360 reports
- Dupilumab: 3,782 reports
- Lenalidomide: 3,411 reports
- Infliximab: 3,303 reports
- Secukinumab: 3,117 reports
- Tofacitinib: 2,822 reports
- Omalizumab: 2,714 reports
- Methotrexate: 2,435 reports
- Natalizumab: 2,159 reports
- Rituximab: 2,152 reports
- Interferon Beta-1a: 2,151 reports
FAERS reports describe events reported after a medicine was taken. They do not prove that the medicine caused an event, measure how often a side effect occurs, or estimate personal risk.
Source: FDA FAERS via openFDA. FAERS data through 2026-06-30. Sources, methods, and limitations.